1-4 of 4
transplantation, autologous
Close
Sort by
Journal Articles

Roundtable: How I treat a newly diagnosed patient with high-risk myeloma

Jonathan L. Kaufman
Journal: Hematology
Hematology Am Soc Hematol Educ Program (2019) 2019 (1): 120–124.
https://doi.org/10.1182/hematology.2019000015
Published: 2019
Journal Articles

Evidence-Based Minireview: What is the optimal timing of anti–PD-1 antibodies in relapsed classical Hodgkin lymphoma?

Pamela Blair Allen, Ann S. LaCasce
Journal: Hematology
Hematology Am Soc Hematol Educ Program (2019) 2019 (1): 249–251.
https://doi.org/10.1182/hematology.2019000077
Published: 2019
Journal Articles

Advances in Biology and Therapy of Multiple Myeloma

Sophie Barillé-Nion, Bart Barlogie, Régis Bataille, P. Leif Bergsagel, Joshua Epstein, Robert G. Fenton, Joth Jacobson, W. Michael Kuehl, John Shaughnessy, Guido Tricot
Journal: Hematology
Hematology Am Soc Hematol Educ Program (2003) 2003 (1): 248–278.
https://doi.org/10.1182/asheducation-2003.1.248
Published: 2003
Journal Articles

Non-Myeloablative Transplantation

David G. Maloney, Brenda M. Sandmaier, Stephen Mackinnon, Judith A. Shizuru
Journal: Hematology
Hematology Am Soc Hematol Educ Program (2002) 2002 (1): 392–421.
https://doi.org/10.1182/asheducation-2002.1.392
Published: 2002